Alan Schrager, MD
Urology · Greenwich, CTNPI 1598772766
Payments from drug & device makers
Across 47 payments — averaging $47.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neotract Inc.$1K
- Astellas Pharma US Inc$642
- Sumitomo Pharma America, Inc.$145
- Urovant Sciences Inc$126
- Myovant Sciences Inc.$104
- Blue Earth Diagnostics$85
- plus $103 from 4 others
What the payments were for
- Food & beverage$91941%
- Education$33515%
- Other$1,00044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neotract Inc. | 3 | $1,051 |
| Astellas Pharma US Inc | 19 | $642 |
| Sumitomo Pharma America, Inc. | 6 | $145 |
| Urovant Sciences Inc | 6 | $126 |
| Myovant Sciences Inc. | 5 | $104 |
| Blue Earth Diagnostics | 3 | $85 |
| AbbVie | 2 | $41 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Pfizer | 1 | $23 |
| Dentsply IH Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$1,000
How this compares
$2,254 in reported general payments places this provider in the 50th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 245 | $2,950 |
| Silodosin | 39 | $2,736 |
| Finasteride | 115 | $1,960 |
| Desmopressin Acetate | 62 | $1,936 |
| Oxybutynin Chloride | 95 | $1,466 |
| NitrofurantoinNitrofurantoin Macrocrystal | 53 | $974 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 33 | $774 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 65 | $632 |
| Cephalexin | 29 | $543 |
| Methenamine Hippurate | 11 | $529 |
| Bicalutamide | 12 | $397 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 60 | $315 |
| Ciprofloxacin Hcl | 23 | $214 |
| Allopurinol | 18 | $204 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $195 |
Paid to pharmacies, not to this prescriber.
Other urology in Greenwich
- Scott SerelsNorwalk$272K
- York MoyMiddlebury$129K
- Daniel KellnerNew Haven$122K
- Jill Peters-GeeFarmington$94K
- Gerard PregenzerEnfield$92K
- Stanton HonigNew Haven$80K
- Sagar PhatakMiddlebury$58K
- Mary SoysterTorrington$58K
- Preston SprenkleNew Haven$57K
- Grace BiggsDerby$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.